| |
| |
|
| Insider
Information: |
Patel Anish |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
394,027 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
394,027 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enliven Therapeutics Ord Shs |
ELVN |
|
2024-05-09 |
0 |
2024-05-09 |
394,027 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-05-09 |
4 |
AS |
$25.06 |
$6,515 |
D/D |
(260) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-05-09 |
4 |
OE |
$2.48 |
$645 |
D/D |
260 |
260 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-05-06 |
4 |
AS |
$22.72 |
$110,769 |
D/D |
(4,875) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-05-06 |
4 |
OE |
$2.48 |
$12,090 |
D/D |
4,875 |
4,875 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-04-11 |
4 |
AS |
$25.03 |
$438,099 |
D/D |
(17,500) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-04-11 |
4 |
OE |
$2.48 |
$36,959 |
D/D |
14,903 |
17,500 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-04-08 |
4 |
AS |
$18.50 |
$90,687 |
D/D |
(4,875) |
2,597 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-03-06 |
4 |
AS |
$15.64 |
$76,239 |
D/D |
(4,875) |
7,472 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
CHIEF OPERATING OFFICER |
• – – |
2024-02-06 |
4 |
AS |
$15.11 |
$73,658 |
D/D |
(4,875) |
12,347 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Chief Operating Officer |
• – – |
2024-01-22 |
4 |
AS |
$15.14 |
$73,783 |
D/D |
(4,875) |
17,222 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Chief Operating Officer |
• – – |
2024-01-02 |
4 |
AS |
$15.00 |
$165,053 |
D/D |
(11,000) |
22,097 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Chief Operating Officer |
• – – |
2023-12-29 |
4 |
AS |
$15.00 |
$300 |
D/D |
(20) |
33,097 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Chief Operating Officer |
• – – |
2023-12-28 |
4 |
AS |
$15.08 |
$37,996 |
D/D |
(2,520) |
33,117 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Chief Operating Officer |
• – – |
2023-12-26 |
4 |
AS |
$15.01 |
$1,531 |
D/D |
(102) |
35,637 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Chief Operating Officer |
• – – |
2023-12-22 |
4 |
AS |
$15.03 |
$14,776 |
D/D |
(983) |
35,739 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Chief Operating Officer |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
I/I |
394,027 |
394,027 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Chief Operating Officer |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
36,722 |
36,722 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
